Cynthia E. Balatoni, Ph.D.
Affiliations: | 2008 | University of California, Los Angeles, Los Angeles, CA |
Google:
"Cynthia Balatoni"Parents
Sign in to add mentor| Michael Teitell | grad student | 2008 | UCLA | |
| (Investigations in TCL1-mediated lymphomagenesis involving polynucleotide phosphorylase and STK39 hypermethylation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Balatoni CE, Dawson DW, Suh J, et al. (2009) Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stress. The American Journal of Pathology. 175: 1653-61 |
| Frank MJ, Dawson DW, Bensinger SJ, et al. (2009) Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas. Blood. 113: 2478-87 |
| Vaysberg M, Balatoni CE, Nepomuceno RR, et al. (2007) Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression. Transplantation. 83: 1114-21 |
| French SW, Dawson DW, Chen HW, et al. (2007) The TCL1 oncoprotein binds the RNase PH domains of the PNPase exoribonuclease without affecting its RNA degrading activity. Cancer Letters. 248: 198-210 |
| Chen HW, Rainey RN, Balatoni CE, et al. (2006) Mammalian polynucleotide phosphorylase is an intermembrane space RNase that maintains mitochondrial homeostasis Molecular and Cellular Biology. 26: 8475-8487 |
| Vaysberg M, Balatoni CE, Nepomuceno RR, et al. (2004) RAPAMYCIN INHIBITS EPSTEIN BARR VIRUS+ B CELL LYMPHOMA PROLIFERATION THROUGH MODULATION OF CELL CYCLE PROTEIN EXPRESSION. Transplantation. 78: 76 |
| Nepomuceno RR, Balatoni CE, Natkunam Y, et al. (2003) Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas. Cancer Research. 63: 4472-80 |